Results 51 to 60 of about 5,416,588 (337)
New NLO Parametrizations of the Parton Distributions in Real Photons
, 2005 We present new NLO sets of parton distributions in real photons based on a
scheme invariant definition of the non-perturbative input. We compare the
theoretical predictions with LEP data and a best fit allows us to constrain the
parameters of the ...19, 233, Albino, Aurenche, Aurenche, Bardeen, Bardeen, Barone, Collaboration, Collaboration, Collaboration, Collaboration, Collaboration, Collaboration, Collaboration, Collaboration, Collaboration, Collaboration, Collaboration, Collaboration, Collaboration, Collaboration, Collaboration, Collaboration, Collaboration, Collaboration, Collaboration, Collaboration, Collaboration, Collaboration, Cornet, Curci, Floratos, Fontannaz, Fontannaz, Fontannaz, Fontannaz, Glück, Glück, Glück, J. Ph. Guillet, Klasen, Kolanoski, Krawczyk, M. Fontannaz, Moch, Moch, Nisius, P. Aurenche, Walsh, Witten, Witten, Zijlstra +52 morecore +4 more sourcesPerformance of molecular inversion probe DR23K and Paragon MAD4HatTeR Amplicon sequencing panels for detection of Plasmodium falciparum mutations associated with antimalarial drug resistance
Malaria JournalBackground Molecular surveillance of drug-resistant Plasmodium falciparum is crucial for malaria control in endemic regions. Two targeted-resequencing tools, the Molecular Inversion Probe (MIP) drug resistance panel DR23K and the Multiplexed Amplicons ...Thomas Katairo, Victor Asua, Bienvenu Nsengimaana, Stephen Tukwasibwe, Francis D. Semakuba, Innocent Wiringilimaana, Brian A. Kagurusi, Caroline Mwubaha, Jackie Nakasaanya, Shreeya Garg, Shahiid Kiyaga, Monica Mbabazi, Kisakye D. Kabbale, Alisen Ayitewala, Samuel L. Nsobya, Moses R. Kamya, Isaac Ssewanyana, Jeffrey A. Bailey, Andrés Aranda-Díaz, Philip J. Rosenthal, Bryan Greenhouse, Jessica Briggs, Melissa D. Conrad +22 moredoaj +1 more sourceDecreased susceptibility of Plasmodium falciparum to both dihydroartemisinin and lumefantrine in northern Uganda
Nature Communications, 2022 In this work, susceptibilities to two key antimalarials, dihydroartemisinin and lumefantrine, were associated with multiple genetic polymorphisms in Plasmodium falciparum, and were lower in northern Uganda, where resistance-mediating mutations have ...Patrick K. Tumwebaze, Melissa D. Conrad, Martin Okitwi, Stephen Orena, Oswald Byaruhanga, Thomas Katairo, Jennifer Legac, Shreeya Garg, David Giesbrecht, Sawyer R. Smith, Frida G. Ceja, Samuel L. Nsobya, Jeffrey A. Bailey, Roland A. Cooper, Philip J. Rosenthal +14 moredoaj +1 more sourceNLO photon parton parametrization using ee and ep data
, 2005 An NLO photon parton parametrization is presented based on the existing
$F_2^\gamma$ measurements from $e^+e^-$ data and the low-$x$ proton structure
function from $ep$ interactions.A. Levy, Aihara, Aivazis, Albino, Aurenche, Bardeen, Blankenbecler, Budnev, Collaboration, Collaboration, Collaboration, Collaboration, Collaboration, Collaboration, Collaboration, Collaboration, Collaboration, Collaboration, Collaboration, Collaboration, Collaboration, Collaboration, Collaboration, Collins, Cornet, Curci, DeWitt, Donnachie, Farrar, Frankfurt, Frixione, Furmanski, Gluck, Gluck, Gordon, Gribov, H. Abramowicz, James, Krawczyk, Levy, Schuler, Thorne, Tung, W. Slominski, Witten +44 morecore +3 more sourcesQuark mass dependence of pseudoscalar masses and decay constants on a
lattice [PDF]
, 2004 Our previous calculations of the sea- and valence-quark mass dependence of
the pseudoscalar meson masses and decay constants is repeated on a 16^3x32
lattice which allows for a better determination of the quantities in question.Bernard, Borici, Colangelo, Collaboration, Collaboration, Collaboration, Collaboration, Collaboration, Collaboration, Collaboration, E. Scholz, F. Farchioni, Fleming, Frezzotti, Gasser, Hasenfratz, I. Montvay, Leutwyler, Lüscher, Montvay, Rupak, Sharpe, Ukawa, Weinberg, Wolff +24 morecore +1 more sourceReal‐World Pediatric Blinatumomab Administration: Access to Outpatient Care Delivery and Impact of a Hospital‐Dispensed Model
Pediatric Blood &Cancer, EarlyView.ABSTRACT
Blinatumomab has been shown to be highly effective for patients with pediatric B‐ALL and has recently become standard of care therapy. Due to its past use in the clinical trial setting, there is limited information available about real‐world administration.Katelyn Oranges, Kelly A. Duffy, Sara McDonough, Evelyn Kurpiewski, R. Jennifer Randall, Allison Barz Leahy, Haley M. Newman, Joyce P. Lee, Stephen P. Hunger, Anne F. Reilly, David T. Teachey, Susan R. Rheingold, Daniel J. Zheng +12 morewiley +1 more sourceOptimizing diabetes care in pregnancy: A systematic review of glycemic targets, treatment initiation, and glucose‐lowering pharmacological management for T1DM, T2DM, and GDM
PregnancyIntroduction Pregnant women with diabetes are at increased risk of adverse maternal and neonatal outcomes, yet the optimal approach to achieving recommended glucose levels and glucose‐lowering pharmacological strategies during pregnancy remains unclear ...Gemma Villanueva, Elise Cogo, Brian Buckley, Jennifer Petkovic, Katrin Probyn, Heather McIntosh, Hanna Bergman, Maria Christou, Ferruccio Pelone, Fatema Kazi, Yanina Sguassero, Meghan Sebastianski, Nicholas Henschke +12 moredoaj +1 more sourceRecent Low x and Diffractive Collider Data
, 2000 Selected recent data from collider experiments pertaining to the
understanding of QCD at low Bjorken-x are reviewed. The status of QCD and Regge
factorisation in hard diffractive interactions is discussed in terms of data
from HERA and the Tevatron., Alvero L, Borras K (CDF Collaboration), CDF Collaboration, Convery M (CDF Collaboration), Cox B, Cox B, Eboli O, Eboli O, Engel R, H1 Collaboration, H1 Collaboration, H1 Collaboration, H1 Collaboration, H1 Collaboration, H1 Collaboration, H1 Collaboration, H1 Collaboration, H1 Collaboration, L3 Collaboration, Mauritz K (D0 Collaboration), OPAL Collaboration, P R Newman, Thorne R, ZEUS Collaboration, ZEUS Collaboration, ZEUS Collaboration, ZEUS Collaboration, ZEUS Collaboration, ZEUS Collaboration, ZEUS Collaboration, ZEUS Collaboration +31 morecore +2 more sourcesPersonalized Selumetinib Dosing in Pediatric Neurofibromatosis Type 1: Insights From a Pilot Therapeutic Drug Monitoring Study
Pediatric Blood &Cancer, EarlyView.ABSTRACT Objective
To evaluate selumetinib exposure using therapeutic drug monitoring (TDM) in pediatric patients with neurofibromatosis type 1 (NF1) and plexiform neurofibromas (PN), assess interpatient pharmacokinetic variability, and explore the relationship between drug exposure, clinical response, and adverse effects.Janka Kovács, Zoltán Köllő, Balázs Gellért Karvaly, Mahmoud Obeidat, Rita Nagy, Péter Hegyi, Brigitta Teutsch, Eszter Tuboly, Miklós Garami +8 morewiley +1 more source